Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
29 01 2019
Historique:
received: 30 07 2018
accepted: 04 09 2018
pubmed: 8 9 2018
medline: 13 11 2019
entrez: 8 9 2018
Statut: ppublish

Résumé

Influenza is responsible for significant morbidity after transplantation. We evaluated T-helper 1/T-helper 2 (Th2) cytokines and interleukin (IL) 10 levels during influenza infection in the posttransplant setting. Serum samples from 277 transplant recipients were analyzed at influenza diagnosis and 28 days later for interferon gamma (IFN-γ), IL-4, IL-13, and IL-10. IL-13 levels were associated with protection against pneumonia and intensive care unit (ICU) admission, whereas the IFN-γ/IL-13 ratio and IL-10 levels were associated with an increased risk of pneumonia and ICU admission. This association was independent of viral load. A skewing of immune responses toward Th2 in transplant patients appears to confer protection from severe influenza infection, independent of viral load.

Identifiants

pubmed: 30192949
pii: 5091250
doi: 10.1093/infdis/jiy535
doi:

Substances chimiques

Cytokines 0

Banques de données

ClinicalTrials.gov
['NCT01256255']

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

535-539

Auteurs

Arnaud G L'Huillier (AG)

Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.

Victor H Ferreira (VH)

Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.

Cedric Hirzel (C)

Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.

Elisa Cordero (E)

Hospital Universitario Virgen del Rocío and Biomedicine Research Institute, Seville, Spain.

Ajit P Limaye (AP)

Division of Infectious Diseases, University of Washington, Seattle.

Gail Reid (G)

Loyola University Medical Center, Chicago, Illinois.

Janet Englund (J)

Pediatric Infectious Diseases, Seattle Children's Research Institute, Washington.

Emily Blumberg (E)

Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Deepali Kumar (D)

Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.

Atul Humar (A)

Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH